Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab
about
Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Validation of a treatment sati ...... us administration of rituximab
@ast
Validation of a treatment sati ...... us administration of rituximab
@en
Validation of a treatment sati ...... us administration of rituximab
@nl
type
label
Validation of a treatment sati ...... us administration of rituximab
@ast
Validation of a treatment sati ...... us administration of rituximab
@en
Validation of a treatment sati ...... us administration of rituximab
@nl
prefLabel
Validation of a treatment sati ...... us administration of rituximab
@ast
Validation of a treatment sati ...... us administration of rituximab
@en
Validation of a treatment sati ...... us administration of rituximab
@nl
P2093
P2860
P3181
P356
P1476
Validation of a treatment sati ...... us administration of rituximab
@en
P2093
Alicyn Campbell
Christina Theodore-Oklota
Christof Wiesner
Gabriel Schnetzler
Louise Humphrey
Stacie Hudgens
P2860
P304
P3181
P356
10.2147/PPA.S108489
P407
P577
2016-09-13T00:00:00Z